5 Financial Stocks Investors Hate But Analysts Love

Jacob Harper |

Here at Equities.com we take a keen interest in the disparity between what the market experts think will happen with plays, and what is actually playing out. The gulf between the analysts and the retail investors is perhaps most pronounced in the financial sector, where opaqueness can lead the two groups to take diametrically opposed positions on plays, with large groups playing long and short against each other.

As we wind down 2013 we thought it would be interesting to look to see what plays were currently splitting the investment community. That is, what financial stocks maintained high marks from analysts, yet were courting bets against them at exceedingly high rates?

To find these plays, we looked for financial stocks that could answer “yes” to the following questions:

1)      Does the stock currently have a short float of 25 percent or higher?

Plays where over 25 percent of shares are being “shorted” (or bet to fall) can definitely be considered to have an unusually high amount of investors betting against them.

2)      Does the stock currently have an analyst consensus rating of “buy” or better?

There are plenty of stocks out there that both the market and experts agree are no good. There are many that the market is actively shorting, but consensus still leans away from recommending investment. A consensus of “buy” or stringer indicates the majority of firms still believe the stoc will defy the shorters and rise in value.

Incredibly, out of all the financial sector stocks currently trading on NASDAQ or the NYSE we only found five stocks that could answer “yes” top both questions. They are:

AmTrust Financial Services, Inc. (AFSI)

Market-Cap: $3.05 billion

Price:  $41.06

P/E: 11.6

Performance YTD: +59.21

Short Float Percentage: 29.06

 

PacWest Bancorp (PACW)

Market-Cap: $1.87 billion

Price: $42.11

P/E: 27.34

Performance YTD: +75.53

Short Float Percentage: 27.92

 

PHH Corporation (PHH)

Market-Cap: $1.34 billion

Price: $23.35

P/E: 10.81

Performance YTD: +2.64

Short Float Percentage: 31.20

 

Radian Group Inc. (RDN)

Market-Cap: $2.49 billion

Price: $14.50

P/E: N/A

Performance YTD: +137.70

Short Float Percentage:  27.06

 

World Acceptance Corp. (WRLD)

Market-Cap: $1.08 billion

Price: $89.91

P/E: 10.86

Performance YTD: +20.45

Short Float Percentage: 30.11

DISCLOSURE: The views and opinions expressed in this article are those of the authors, and do not represent the views of equities.com. Readers should not consider statements made by the author as formal recommendations and should consult their financial advisor before making any investment decisions. To read our full disclosure, please go to: http://www.equities.com/disclaimer

Companies

Symbol Name Price Change % Volume
AFSI AmTrust Financial Services Inc. 27.73 0.98 3.66 1,008,868
RDN Radian Group Inc. 16.08 0.74 4.82 4,325,090
WRLD World Acceptance Corporation 67.49 2.05 3.13 158,778
PACW PacWest Bancorp 55.34 0.43 0.78 868,010
PHH PHH Corp 15.50 0.30 1.97 588,684
BSVN Balsam Ventures Inc New n/a n/a n/a 0

Comments

Emerging Growth

Immunovaccine Inc.

Immunovaccine Inc is clinical stage biopharmaceutical company. The Company develops products based on its proprietary vaccine enhancement platform in T cell activating therapies for cancer.

Private Markets

Wealthfront

Wealthfront is an automated investment service that serves as an alternative to traditional financial advisory services. The company manages a diversified, continually rebalanced portfolio of index funds on their clients’…

Spotify

Spotify is a online music service offering providing digital content from a range of record labels and artists. Users can browse through the interface by artist, album, genre, playlist, record…